Comparison

CaV1.3 antagonist-1 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 5 mg
Item no. HY-134542-5mg
CASRN 1391385-57-1
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
CaV1.3 antagonist-1 is a potent and highly selective CaV1.3 L-type calcium channel (LTCC) antagonist with an IC50 of 1.7 μM. CaV1.3 antagonist-1 inhibits CaV1.3 LTCC >600-fold more potently than CaV1.2 LTCC. CaV1.3 antagonist-1, a cyclopentyl derivative, has the potential for Parkinson's disease research[1].
StorageTemperature
4°C (Powder, protect from light)
Shipping
Room Temperature
Manufacturers Applications
Neuroscience-Neurodegeneration
MolecularWeight
334.80
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease
Solubility
DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target
Calcium Channel
Isoform
L-type calcium channel
Pathway
Membrane Transporter/Ion Channel; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close